Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
473 studies found for:    "Neuroblastoma"
Show Display Options
RSS Create an RSS feed from your search for:
"Neuroblastoma"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Neuroblastoma Precision Trial
Condition: Neuroblastoma
Intervention: Other: Gene panel sequencing of tumor specimens
2 Terminated
Has Results
Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Temsirolimus;   Drug: Irinotecan;   Procedure: Surgical Resection of Primary Tumor;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Etoposide;   Drug: Cisplatin;   Drug: Topotecan;   Procedure: PBSC;   Radiation: Radiation Therapy;   Drug: 13-cis-retinoic acid
3 Completed Therapy for Children With Advanced Stage High Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Topotecan, Cyclophosphamide, Cisplatin, Doxorubicin, Etoposide, Ifosfamide, Carboplatin;   Procedure: Peripheral Blood Stem Cell Transplant
4 Completed Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Genetic: fluorescence in situ hybridization;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: mutation analysis;   Genetic: protein analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: microscopy
5 Completed Chemotherapy in Treating Children With Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: buthionine sulfoximine;   Drug: melphalan
6 Completed 131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Radiation: iobenguane I 131
7 Completed Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: vincristine sulfate;   Procedure: conventional surgery
8 Completed
Has Results
Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: irinotecan hydrochloride;   Drug: temozolomide
9 Unknown  Surgery in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Intervention: Procedure: surgical procedure
10 Completed Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma.
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: vincristine sulfate;   Procedure: conventional surgery
11 Completed Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: vincristine sulfate
12 Not yet recruiting Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
Condition: Neuroblastoma
Interventions: Drug: Ch14.18;   Biological: NK Cells;   Drug: Lenalidomide
13 Completed
Has Results
hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
Condition: Neuroblastoma
Intervention: Biological: hu14.18-Interleukin-2 fusion protein
14 Active, not recruiting Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients
Condition: Neuroblastoma
Intervention: Biological: 14g2a.zeta chimeric receptor transduced autologous EBV specific cytotoxic T-lymphocytes (EBV-CTL) w/o lymphodepletion
15 Completed Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: becatecarin
16 Completed Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: gene-modified tumor cell vaccine therapy;   Biological: interleukin-2 gene
17 Completed Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: monoclonal antibody 3F8;   Biological: sargramostim
18 Active, not recruiting Surgery in Treating Children With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Biological: sargramostim;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: radiation therapy
19 Recruiting Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)
Condition: Neuroblastoma
Intervention: Device: FLT-PET
20 Completed
Has Results
Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide
Condition: Neuroblastoma
Interventions: Drug: DFMO;   Drug: Etoposide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.